| Page 1511 | Kisaco Research
 

David Armstrong

Professor of Surgery, Co-Director
USC Limb Preservation Program

David G. Armstrong, DPM, PhD, is an internationally recognized leader in the field of podiatric surgery, diabetic foot, limb preservation, tissue repair and wound healing. He is founder and co-director of the Southwestern Academic Limb Salvage Alliance (SALSA), a clinical and research collaborative. 

 

David Armstrong

Professor of Surgery, Co-Director
USC Limb Preservation Program

David Armstrong

Professor of Surgery, Co-Director
USC Limb Preservation Program

David G. Armstrong, DPM, PhD, is an internationally recognized leader in the field of podiatric surgery, diabetic foot, limb preservation, tissue repair and wound healing. He is founder and co-director of the Southwestern Academic Limb Salvage Alliance (SALSA), a clinical and research collaborative. 

 

As director of USC’s Center to Stream Healthcare in Place (C2SHIP), he is advancing the latest research in consumer wearables and other health technologies. In 2021, he received a USC Stevens Technology Commercialization Award for his method for treating chronic diabetic foot ulcers, just one of multiple patents he holds. 

Dr. Armstrong is coeditor of the American Diabetes Association textbook, Clinical Care of the Diabetic Foot, now in its third edition. He is responsible for more than 100 books or book chapters, along with 600 peer-reviewed research papers in leading medical journals.  

His achievements have garnered multiple honors, including the 2010 American Diabetes Association’s Roger E. Pecoraro Award for Lifetime Achievement in Diabetic Foot Care, the highest honor in the field. 

Dr. Armstrong is founding president of the American Limb Preservation Society (ALPS), which is bringing together clinicians to help eliminate preventable amputations in the United States and worldwide. He and his Keck Medicine of USC team are working to achieve that goal for people with diabetes over the next generation.  

 

 

Chris Broderick

Chief Executive Officer
Merakris Therapeutics

Chris Broderick

Chief Executive Officer
Merakris Therapeutics

Chris Broderick

Chief Executive Officer
Merakris Therapeutics
 

Imtiaz Shams

CEO
Flox Ai

Imtiaz Shams

CEO
Flox Ai

Imtiaz Shams

CEO
Flox Ai
 

Prashant Tiwari

Former Executive Director, Software Platforms at Volkswagen

Prashant Tiwari

Former Executive Director, Software Platforms at Volkswagen

Prashant Tiwari

Former Executive Director, Software Platforms at Volkswagen
 

John Thompson

Global Head, Artificial Intelligence (AI) and Rapid Data Lab
CSL Behring

John is an international technology executive with over 35 years of experience in the fields of data, advanced analytics and artificial intelligence (AI).

John Thompson

Global Head, Artificial Intelligence (AI) and Rapid Data Lab
CSL Behring

John Thompson

Global Head, Artificial Intelligence (AI) and Rapid Data Lab
CSL Behring

John is an international technology executive with over 35 years of experience in the fields of data, advanced analytics and artificial intelligence (AI).

John has been responsible for the global advanced analytics and AI function at a leading biopharmaceutical company where he led a team that developed and deployed over 25 analytical applications in 3 years.  John was an Executive Partner at Gartner, where he was management consultant to market leading companies in the areas of digital transformation, data monetization and advanced analytics.  Before Gartner, John was responsible for the advanced analytics business unit of the Dell Software Group.

John is the author of the best-selling book – Analytics Teams: Leveraging analytics and artificial intelligence for business improvement.  The book was published in June 2020 and outlines how to hire and manage high performance advanced analytics teams.  The book outlines how to engage with executives and senior managers.  How to select and undertake analytics projects that change and improve how a business operates.

John is co-author of the bestselling book – Analytics: How to win with Intelligence, which debuted on Amazon as the #1 new book in Analytics in 2017.  Analytics is a book that guides non-technical executives through the journey of creating an analytics function, funding initiatives, and driving change in business operations through data and applied analytical applications.

 

John’s new book – The Future of Data, will be published in 2022.

 

Xiaoyong Liu

Director, AI Platform
Alibaba

Xiaoyong Liu

Director, AI Platform
Alibaba

Xiaoyong Liu

Director, AI Platform
Alibaba
 

Robert Crousore

Managing Partner
Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

Robert Crousore

Managing Partner
Health Frontier Ventures

Robert Crousore

Managing Partner
Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

  • Has successfully managed a global commercial organization in the wound care business.
  • Has a number of patent credits for products in the wound care industry.
  • Sits on multiple boards of healthcare technology companies.
  • His passion is creating meaningful changes in patient care by combining great products with great teams  that are focused on empowering improved clinical and financial outcomes.

 

 

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential.

Thomas Busby

Vice President
Outcome Capital

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

 

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

 

Brannon Morisoli

Director
SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr.

Brannon Morisoli

Director
SWK Holdings

Brannon Morisoli

Director
SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr. Morisoli began his career at Neurografix, a startup medical technology company in Santa Monica, CA that was doing groundbreaking work in the MRI imaging of peripheral nerves. While with Neurografix, he was published in two leading neurology journals. Brannon graduated from UCLA with a B.S., was awarded a fellowship and graduated from the University of Notre Dame with an M.B.A, and was awarded a Samson Fellowship from the University of Wisconsin Law School, where he graduated with a J.D. Mr. Morisoli is an inactive member of the State Bar of Wisconsin